Fig (2).

Immune and signaling pathway characteristics of the three molecular subtypes. (A) Differential gene expression levels and clinical characteristics between molecular subtypes. (B) Estimation of Stromal and Immune cells in Malignant Tumors using Expression data (ESTIMATE) scores. (C) Innate immunity and adaptive immunity scores. (D) Comparison of 27 immune components evaluated using single-sample Gene Set Enrichment Analysis (ssGSEA). (E) Gene Set Enrichment Analysis (GSEA) of differentially expressed genes between the molecular subtypes.